WoodTrust Financial Corp Has $10.54 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

WoodTrust Financial Corp cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.0% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 21,302 shares of the healthcare conglomerate’s stock after selling 426 shares during the quarter. UnitedHealth Group accounts for 1.1% of WoodTrust Financial Corp’s investment portfolio, making the stock its 12th largest holding. WoodTrust Financial Corp’s holdings in UnitedHealth Group were worth $10,538,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the business. Bell Investment Advisors Inc increased its holdings in shares of UnitedHealth Group by 4.8% during the fourth quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock valued at $276,000 after acquiring an additional 24 shares in the last quarter. Harbor Investment Advisory LLC increased its holdings in shares of UnitedHealth Group by 3.2% during the first quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock valued at $17,783,000 after acquiring an additional 1,129 shares in the last quarter. Verdence Capital Advisors LLC grew its holdings in UnitedHealth Group by 2.1% during the fourth quarter. Verdence Capital Advisors LLC now owns 16,941 shares of the healthcare conglomerate’s stock worth $8,919,000 after buying an additional 342 shares in the last quarter. Austin Private Wealth LLC grew its holdings in UnitedHealth Group by 9.8% during the first quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock worth $573,000 after buying an additional 111 shares in the last quarter. Finally, Bellecapital International Ltd. grew its holdings in UnitedHealth Group by 1.4% during the fourth quarter. Bellecapital International Ltd. now owns 13,823 shares of the healthcare conglomerate’s stock worth $7,277,000 after buying an additional 193 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages recently issued reports on UNH. Wells Fargo & Company decreased their price target on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a report on Monday, April 8th. Morgan Stanley decreased their price target on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a report on Friday, April 5th. Truist Financial restated a “buy” rating and issued a $600.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Robert W. Baird initiated coverage on UnitedHealth Group in a research note on Thursday, May 30th. They issued an “outperform” rating and a $597.00 price objective for the company. Finally, StockNews.com downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Friday. Three investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average target price of $579.74.

UnitedHealth Group Stock Performance

Shares of UNH opened at $509.26 on Friday. The stock’s 50-day simple moving average is $498.34 and its 200 day simple moving average is $501.96. The stock has a market capitalization of $468.72 billion, a price-to-earnings ratio of 31.13, a price-to-earnings-growth ratio of 1.48 and a beta of 0.58. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm’s quarterly revenue was up 8.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $6.26 EPS. Research analysts forecast that UnitedHealth Group Incorporated will post 27.55 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were issued a $2.10 dividend. The ex-dividend date was Monday, June 17th. This represents a $8.40 annualized dividend and a dividend yield of 1.65%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.